scispace - formally typeset
C

Constantinos Christodoulides

Researcher at University of Oxford

Publications -  49
Citations -  2658

Constantinos Christodoulides is an academic researcher from University of Oxford. The author has contributed to research in topics: Adipogenesis & Adipose tissue. The author has an hindex of 21, co-authored 42 publications receiving 2315 citations. Previous affiliations of Constantinos Christodoulides include University of Cambridge & University of Salford.

Papers
More filters
Journal ArticleDOI

Adipogenesis and WNT signalling.

TL;DR: Manipulating the WNT pathway to alter adipose cellular makeup constitutes an attractive drug-development target to combat obesity-associated metabolic complications.
Journal ArticleDOI

Expression of the thermogenic nuclear hormone receptor coactivator PGC-1alpha is reduced in the adipose tissue of morbidly obese subjects.

TL;DR: In this article, quantitative real-time PCR has been used in human tissue to demonstrate that PGC1alpha mRNA levels in subcutaneous fat are three-fold lower in morbidly obese than in slim subjects.
Journal ArticleDOI

WNT10B mutations in human obesity

TL;DR: While the pedigree analysis in the case of C256Y WNT10B does not provide definitive proof of a causal link of this variant with obesity, the finding of a non-functioning WNT 10B allele in a human family affected by obesity should encourage further study of this gene in other obese populations.
Journal ArticleDOI

The Link Between Nutritional Status and Insulin Sensitivity Is Dependent on the Adipocyte-Specific Peroxisome Proliferator–Activated Receptor-γ2 Isoform

TL;DR: The results indicate that insulin resistance associated with ablation of PPARgamma2 is not the result of lipodystrophy and suggests a specific role for PPAR Gamma2 in maintaining insulin sensitivity independently of its effects on adipogenesis, and raises the intriguing notion that PPARGamma2 may be necessary for the adverse effects of a high-fat diet on carbohydrate metabolism.
Journal ArticleDOI

The Wnt antagonist Dickkopf-1 and its receptors are coordinately regulated during early human adipogenesis.

TL;DR: The involvement of Dkk1 in human but not murine adipogenesis indicates that inter-species differences exist in the molecular control of this process, and further knowledge of the pathways involved specifically in human adipocyte differentiation might ultimately be of clinical relevance.